I-US Drug Administration igunyaze imitha yeglucose yokuqala eguquguqukayo engasetshenziswa namasirinji e-insulin

I-US Food and Drug Administration igunyaze “uhlelo oludidiyelwe oluqinile lokuqapha ushukela wegazi” e-China mhla zingama-27 ukuze luqaphe amazinga kashukela ezigulini ezinesifo sikashukela ezineminyaka engaphezu kwengu-2 ubudala, futhi lungasetshenziswa nama-insulin auto-injection.Neminye imishini esetshenziswa ndawonye.

Leli qapha elibizwa ngokuthi “i-Dkang G6” liyingqapheli likashukela wegazi elikhudlwana kancane kune-dime futhi libekwe esikhumbeni sesisu ukuze abanesifo sikashukela bakwazi ukukala ushukela wegazi ngaphandle kokudinga umunwe.Imonitha ingasetshenziswa njalo emahoreni ayi-10.Shintsha kanye ngosuku.Ithuluzi lidlulisela idatha kusofthiwe yezokwelapha yeselula njalo emizuzwini emi-5, futhi liyaxwayisa uma i-glucose yegazi iphezulu kakhulu noma iphansi kakhulu.

Ithuluzi lingasetshenziswa namanye amathuluzi okulawula i-insulin njengama-insulin autoinjectors, amaphampu e-insulin, namamitha eglucose asheshayo.Uma isetshenziswa kanye nomjovo we-insulin ozenzakalelayo, ukukhishwa kwe-insulin kuqalwa lapho ushukela wegazi ukhuphuka.

Umuntu ofanelekile ophethe i-US Drug Administration uthe: "Ingasebenza ngemishini ehlukene ehambisanayo ukuze ivumele iziguli ukuthi zenze amathuluzi okulawula isifo sikashukela aqondene nomuntu siqu."

Ngenxa yokuhlanganiswa kwayo okungenazihibe nezinye izinto zokusebenza, i-US Pharmacopoeia ihlukanise i-Dekang G6 “njengeyesibili” (isigaba sokulawula esikhethekile) emishinini yezokwelapha, inikeze lula ukuthuthukiswa kokuqapha okuhlanganisiwe okuqhubekayo kweglucose yegazi.

I-US Pharmacopoeia ihlole izifundo ezimbili zomtholampilo.Isampula yayihlanganisa izingane ezingu-324 ezineminyaka engaphezu kwengu-2 kanye nabantu abadala abanesifo sikashukela.Akukho ukusabela okubi kakhulu okutholakele phakathi nesikhathi sokuqapha sezinsuku eziyi-10.